ULEU07047 / RSRB20123 / Michael BeckerResearch Question:
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This study is being performed to develop assays to determine the impact of the therapy
patients receive for treatment of AML or MDS and to determine if these tests can identify
those patients who are at a greater risk for having their disease relapse.
Lead Researcher (Principal Investigator)
Michael Becker, MD
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search